Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs Gemcitabine + Cisplatin in Advanced Pancreatic Cancer
NCT00813696Phase 3Unknown
- Sponsor
- Oncology Institute of Bari
- Start
- Apr 2002
- Primary completion
- Mar 2009
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in pancreatic cancer (PC), sponsored by Oncology Institute of Bari. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00813696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813696.